Antliabio110 - A novel long-acting subcutaneous peptide-based therapy for the treatment of treatment resistant hypertension (rHTN)
Antliabio 111 - A novel long-acting peptide-based therapy for the treatment of pulmonary arterial hypertension
Antliabio 112 - A novel long-acting peptide-based therapy for the treatment of chronic heart failure (HFpEF and HFrEF)
Antliabio 113 - A novel long-acting peptide-based therapy for the treatment of severe asthma
Antliabio210 - A novel long-acting peptide-based therapy for the treatment of multiple cardiovascular, pulmonary, and metabolic diseases
Antliabio310 - A novel long-acting peptide-based therapy for the treatment of cardiovascular diseases
Copyright © 2023 Antlia Bioscience, Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.